Wujun Chen

2.9k total citations · 1 hit paper
73 papers, 2.0k citations indexed

About

Wujun Chen is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wujun Chen has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 22 papers in Cancer Research and 20 papers in Surgery. Recurrent topics in Wujun Chen's work include MicroRNA in disease regulation (15 papers), Cholesterol and Lipid Metabolism (15 papers) and Circular RNAs in diseases (9 papers). Wujun Chen is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cholesterol and Lipid Metabolism (15 papers) and Circular RNAs in diseases (9 papers). Wujun Chen collaborates with scholars based in China, United States and Canada. Wujun Chen's co-authors include Dongming Xing, Yudong Wu, Renshuai Zhang, Chao‐Ke Tang, Kai Yin, Yuchang Fu, Jie Wang, Guojun Zhao, Dongming Xing and Zhu Guo and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Coordination Chemistry Reviews.

In The Last Decade

Wujun Chen

71 papers receiving 2.0k citations

Hit Papers

New-generation advanced PROTACs as potential therapeutic ... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wujun Chen China 28 1.1k 488 387 310 254 73 2.0k
Peng Sun China 28 1.3k 1.2× 683 1.4× 248 0.6× 240 0.8× 350 1.4× 114 2.5k
Rezvan Najafi Iran 27 1.3k 1.2× 680 1.4× 209 0.5× 268 0.9× 540 2.1× 122 2.7k
Luis Rodriguez-Menocal United States 17 1.3k 1.2× 406 0.8× 230 0.6× 187 0.6× 159 0.6× 22 2.3k
Feng Kong China 32 1.4k 1.3× 410 0.8× 330 0.9× 166 0.5× 374 1.5× 123 2.7k
Haohuan Li China 27 834 0.8× 362 0.7× 161 0.4× 172 0.6× 205 0.8× 140 2.1k
Hanno Huwer Germany 33 1.2k 1.1× 539 1.1× 488 1.3× 362 1.2× 335 1.3× 99 3.2k
Wei Han China 21 903 0.8× 387 0.8× 197 0.5× 530 1.7× 293 1.2× 80 2.1k
Tianhui Hu China 31 1.4k 1.3× 439 0.9× 177 0.5× 229 0.7× 364 1.4× 111 2.7k
Manash K. Paul United States 26 1.3k 1.2× 364 0.7× 261 0.7× 389 1.3× 715 2.8× 72 3.0k
Yongchuan Deng China 24 914 0.8× 427 0.9× 197 0.5× 247 0.8× 498 2.0× 53 2.4k

Countries citing papers authored by Wujun Chen

Since Specialization
Citations

This map shows the geographic impact of Wujun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wujun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wujun Chen more than expected).

Fields of papers citing papers by Wujun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wujun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wujun Chen. The network helps show where Wujun Chen may publish in the future.

Co-authorship network of co-authors of Wujun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wujun Chen. A scholar is included among the top collaborators of Wujun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wujun Chen. Wujun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chao, et al.. (2024). Recent advances in polysulfide-based prodrug nanomedicines for cancer therapy. Coordination Chemistry Reviews. 519. 216138–216138. 5 indexed citations
2.
Wang, Jie, et al.. (2024). Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering. Materials Today Bio. 26. 101068–101068. 13 indexed citations
3.
Yan, Saisai, Qing Liu, Bing Liang, et al.. (2024). Airborne microbes: sampling, detection, and inactivation. Critical Reviews in Biotechnology. 45(3). 556–590. 7 indexed citations
4.
Wang, Chao, Yujing Zhang, Wujun Chen, Yudong Wu, & Dongming Xing. (2024). New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Molecular Cancer. 23(1). 110–110. 79 indexed citations breakdown →
5.
Liu, Xinlin, Junwen Deng, Yang Yuan, et al.. (2023). Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]. Pharmacology & Therapeutics. 243. 108336–108336. 1 indexed citations
6.
Wu, Yudong, Wujun Chen, Chao Wang, & Dongming Xing. (2023). Nanozyme-activating prodrug therapies: A review. Chinese Chemical Letters. 35(2). 109096–109096. 21 indexed citations
7.
Chen, Wujun, Yudong Wu, Bing Liang, et al.. (2023). The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis. International Journal of Biological Sciences. 19(9). 2879–2896. 52 indexed citations
8.
Wang, Yanyan, Bing Liang, Wujun Chen, et al.. (2023). High antipersister activity of a promising new quinolone drug candidate in eradicating uropathogenic Escherichia coli persisters and persistent infection in mice. Journal of Applied Microbiology. 134(9). 3 indexed citations
9.
Chen, Wujun, et al.. (2023). Long term exercise-derived exosomal LncRNA CRNDE mitigates myocardial infarction injury through miR-489-3p/Nrf2 signaling axis. Nanomedicine Nanotechnology Biology and Medicine. 55. 102717–102717. 10 indexed citations
10.
Chen, Wujun, Yudong Wu, Jie Wang, et al.. (2023). Clinical advances in TNC delivery vectors and their conjugate agents. Pharmacology & Therapeutics. 253. 108577–108577. 10 indexed citations
11.
Guo, Zhaoyang, Yaqing Wang, Hongfei Xiang, et al.. (2023). The Role of IL-6 and TMEM100 in Lumbar Discogenic Pain and the Mechanism of the Glycine-Serine-Threonine Metabolic Axis: A Metabolomic and Molecular Biology Study. Journal of Pain Research. Volume 16. 437–461. 9 indexed citations
12.
Liu, Xinlin, Junwen Deng, Renshuai Zhang, et al.. (2023). The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy. Frontiers in Immunology. 14. 1335252–1335252. 12 indexed citations
13.
Chen, Wujun, Bing Liang, Xiaolin Wu, et al.. (2022). Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection. Journal of Pharmaceutical Analysis. 13(3). 255–261. 22 indexed citations
14.
Chen, Wujun, Shuai Wang, & Dongming Xing. (2021). New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis. Journal of Inflammation Research. Volume 14. 5251–5271. 18 indexed citations
15.
Zhang, Tingting, Yu Liu, Nannan Lu, et al.. (2021). A novel artificial peroxisome candidate based on nanozyme with excellent catalytic performance for biosensing. Biosensors and Bioelectronics. 196. 113686–113686. 42 indexed citations
16.
Chen, Wujun, Shun Zhang, Jianfeng Wu, et al.. (2020). Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clinica Chimica Acta. 507. 236–241. 108 indexed citations
17.
Chen, Wujun, Shuai Wang, Yudong Wu, et al.. (2020). Immunogenic cell death: A link between gut microbiota and anticancer effects. Microbial Pathogenesis. 141. 103983–103983. 15 indexed citations
18.
Wang, Pingping, et al.. (2013). Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: Role of ATGL and HSL. Biochimie. 95(8). 1650–1654. 18 indexed citations
19.
Lv, Yun-Cheng, Kai Yin, Yuchang Fu, et al.. (2013). Posttranscriptional Regulation of ATP-Binding Cassette Transporter A1 in Lipid Metabolism. DNA and Cell Biology. 32(7). 348–358. 31 indexed citations
20.
Chen, Wujun, Kai Yin, Guojun Zhao, Yuchang Fu, & Chao‐Ke Tang. (2012). The magic and mystery of MicroRNA-27 in atherosclerosis. Atherosclerosis. 222(2). 314–323. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026